Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine U300 vs Insulin Degludec U100 in Type 2 Diabetes
NCT04692415Phase 4Completed
- Sponsor
- University of Split School of Medicine
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec, insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by University of Split School of Medicine. Started Dec 2018; status: completed.
02
Drugs
insulin degludecinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04692415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04692415.